Skip to main content
. 2018 May 26;8(5):e020294. doi: 10.1136/bmjopen-2017-020294

Table 1.

SPIRIT flow chart for Trial23

Study period
Enrolment/
allocation
Postallocation Close-out
Baseline screen Second screen Third screen
Timepoint January 2017* February 2017–September 2018 January 2020–September 2021 January 2023– September 2024 1 October 2025†
Enrolment
 Eligibility X
 Allocation X
Intervention
 HPV arm (CYT+HPV) <—> <—>‡ <—>
 Present programme arm (CYT) <—> <—> <—>
Assessment
 Baseline screen X
 Second screen X
 Third screen X
 Final X

*All women born in 1994 living in Denmark in January 2017 were randomly allocated to HPV or present programme arm.

†End-of-study allowing for 1 year extra for women followed up due to abnormal cytology in former screening rounds.

‡Women with positive HPV test and normal cytology at baseline are retested after 3 years for both HPV and cytology.

CYT, cytology; HPV, human papillomavirus; SPIRIT, Standard Protocol Items: Recommendations for Interventional Trials.